29. Lamia Tazi
Designation: Chairwoman and CEO
Tazi assumed her current role at Sothema in 2019. The company employs 1,400 people and has 35 multinational laboratories and a plant production capacity of 60 million units per year. Sothema generated $217 million in revenues in 2022. It has a presence in Morocco, West Africa, Yemen, Oman, France, and Portugal. The company’s international partners include Lilly, Merck, Sanofi, GSK, Novartis, GenPharm, Biopharm, and Aspen Holdings. Tazi is also the head pharmacist and managing director of innovation at Advanced Scientific Developments and a board member at West Afric Pharma, Azerys, Leiden Pharma, and Axess Pharma.